Adherence to Topical Medication in Patients with Inflammatory Eye Disease

References

• Asiedu K, Abu SL. The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: a review. J Curr Ophthalmol. 2018;31(1):8–15. doi:https://doi.org/10.1016/j.joco.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Deokule S, Sadiq S, Shah S. Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol Opt. 2004;24(1):9–15. doi:https://doi.org/10.1046/j.1475-1313.2003.00155.x.
   PubMed Web of Science ®Google Scholar
• Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115(8):1327.e1-3.doi:https://doi.org/10.1016/j.ophtha.2007.11.023.
   Web of Science ®Google Scholar
• Ko ML, Wei KL, Ho YJ, Peng PH, Lu HHS. Knowledge of medications among patients with glaucoma in Taiwan. J Formos Med Assoc. 2019;118(1 Pt 3):457–462. doi:https://doi.org/10.1016/j.jfma.2018.07.011.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Shtein RM, Coleman AL, Herndon L, Lee PP. Why Patients with glaucoma lose vision: the patient perspective. J Glaucoma. 2016;25(7):e668–e675. doi:https://doi.org/10.1097/IJG.0000000000000320.
   PubMed Web of Science ®Google Scholar
• McDonald S, Ferguson E, Hagger MS, Foss AJE, King AJ. A theory-driven qualitative study exploring issues relating to adherence to topical glaucoma medications. Patient Prefer Adherence. 2019;13:819–828. doi:https://doi.org/10.2147/PPA.S174922.
   PubMed Web of Science ®Google Scholar
• Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007;144(4):533–540. doi:https://doi.org/10.1016/j.ajo.2007.06.012.
   PubMed Web of Science ®Google Scholar
• Djafari F, Lesk MR, Harasymowycz PJ, Desjardins D, Lachaine J. Determinants of adherence to glaucoma medical therapy in a long-term patient population. J Glaucoma. 2009;18(3):238–243. doi:https://doi.org/10.1097/IJG.0b013e3181815421.
   PubMed Web of Science ®Google Scholar
• Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11):S30–S36. doi:https://doi.org/10.1016/j.ophtha.2009.06.024.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316.doi:https://doi.org/10.1016/j.ophtha.2015.03.026.
   PubMed Web of Science ®Google Scholar
• Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol. 2009;127(6):732–736. doi:https://doi.org/10.1001/archophthalmol.2009.96.
   PubMedGoogle Scholar
• Hennessy AL, Katz J, Covert D, Protzko C, Robin AL. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss. Ophthalmology. 2010;117(12):2345–2352. doi:https://doi.org/10.1016/j.ophtha.2010.03.040.
   PubMed Web of Science ®Google Scholar
• Tatham AJ, Sarodia U, Gatrad F, Awan A. Eye drop instillation technique in patients with glaucoma. Eye (Lond). 2013;27(11):1293–1298. doi:https://doi.org/10.1038/eye.2013.187.
   PubMed Web of Science ®Google Scholar
• Rajurkar K, Dubey S, Gupta PP, John D, Chauhan L. Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018;30(2):125–129. doi:https://doi.org/10.1016/j.joco.2017.09.002.
   PubMed Web of Science ®Google Scholar
• Na KH, Yoo C, Park JH, Kim YY. Eye drop dispenser type and medication possession ratio in patients with glaucoma: single-use containers versus multiple-use bottles. Am J Ophthalmol. 2018;188:9–18. doi:https://doi.org/10.1016/j.ajo.2018.01.011.
   PubMed Web of Science ®Google Scholar
• Lampert A, Bruckner T, Haefeli WE, Seidling HM. Improving eye-drop administration skills of patients - a multicenter parallel-group cluster-randomized controlled trial. PLoS One. 2019;14(2):e0212007. doi:https://doi.org/10.1371/journal.pone.0212007.
   PubMed Web of Science ®Google Scholar
• Choy BNK, Zhu MM, Pang JCS. et al. Factors associated with poor eye drop administration technique and the role of patient education among Hong Kong elderly population. J Ophthalmol. 2019;2019:5962065. doi:https://doi.org/10.1155/2019/5962065.
   PubMed Web of Science ®Google Scholar
• Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M, Cunningham ET Jr., Arévalo JF. Noninfectious uveitis: strategies to optimize treatment compliance and adherence. Clin Ophthalmol. 2015;9:1477–1481. doi:https://doi.org/10.2147/OPTH.S36650.
   PubMed Web of Science ®Google Scholar
• Sabate E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization (WHO); 2003. http://www.who.int/chp/knowledge/publications/adherence_full_report.pdfWorld/Health/Organization/analysis/of/the/barrier/of/adherence/to/chronic/medications. Accessed 20 July 2019.
   Google Scholar
• Mansberger SL. Are you compliant with addressing glaucoma adherence? Am J Ophthalmol. 2010;149(1):1–3. doi:https://doi.org/10.1016/j.ajo.2009.08.011.
   PubMed Web of Science ®Google Scholar
• Morse AR. Improving medication adherence to reduce vision loss in patients with glaucoma: low hanging fruit? Ophthalmology. 2015;122(7):1280–1282. doi:https://doi.org/10.1016/j.ophtha.2015.04.019.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Dayno M, Robin AL. Systematic review of educational interventions to improve glaucoma medication adherence: an update in 2015. Expert Rev Ophthalmol. 2016;11(1):5–20. doi:https://doi.org/10.1586/17469899.2016.1134318.
   PubMed Web of Science ®Google Scholar
• Hahn SR. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology. 2009;116(11):S37–S42. doi:https://doi.org/10.1016/j.ophtha.2009.06.023.
   PubMed Web of Science ®Google Scholar
• Waterman H, Evans JR, Gray TA, Henson D, Harper R. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev. 2013;4:CD006132. doi:https://doi.org/10.1002/14651858.CD006132.pub3.
   PubMed Web of Science ®Google Scholar
• Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953–961. doi:https://doi.org/10.1016/j.ophtha.2004.12.035.
   PubMed Web of Science ®Google Scholar
• Accessed July 20, 2019. https://www.glaucoma.org/q-a/how-long-do-i-need-to-wait-between-putting-in-one-glaucoma-medication-and-then-putting-in-a-second-g.php
   Google Scholar
• Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. Clinical guideline [CG76] Published date January, 2009. Accessed July 20, 2019. https://www.nice.org.uk/guidance/cg76/chapter/Introduction
   Google Scholar
• Okeke CO, Quigley HA, Jampel HD, et al. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients. Ophthalmology. 2009;116(12):2286–2293.doi:https://doi.org/10.1016/j.ophtha.2009.05.026.
   PubMed Web of Science ®Google Scholar
• Tsumura T, Kashiwagi K, Suzuki Y, et al. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan. Int Ophthalmol. 2019;39(2):375–383.doi:https://doi.org/10.1007/s10792-018-0820-7.
   PubMed Web of Science ®Google Scholar
• Papagiannuli E, Edmunds MR, Scollo P, S S, MacKenzie A, Murray PI. Do demographic factors influence uveitis patients’ understanding of uveitis? Ocul Immunol Inflamm. 2017;25(6):790–796. doi:https://doi.org/10.1080/09273948.2016.1175638.
   PubMed Web of Science ®Google Scholar
• Tse AP, Shah M, Jamal N, Shaikh A. Glaucoma treatment adherence at a United Kingdom general practice. Eye (Lond). 2016;30(8):1118–1122. doi:https://doi.org/10.1038/eye.2016.103.
   PubMed Web of Science ®Google Scholar
• Wolfram C, Stahlberg E, Pfeiffer N. Patient-reported nonadherence with glaucoma therapy. J Ocul Pharmacol Ther. 2019;35(4):223–228. doi:https://doi.org/10.1089/jop.2018.0134.
   PubMed Web of Science ®Google Scholar
• Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2009;23(4):924–932. doi:https://doi.org/10.1038/eye.2008.103.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr. Exogenous factors influencing endogenous inflammation: what can patients do to improve control of their own uveitis? Br J Ophthalmol. 2010;94(7):813–814. doi:https://doi.org/10.1136/bjo.2009.178780.
   PubMed Web of Science ®Google Scholar
• Tarn DM, Paterniti DA, Kravitz RL, et al. How much time does it take to prescribe a new medication? Patient Educ Couns. 2008;72(2):311–319.doi:https://doi.org/10.1016/j.pec.2008.02.019.
   PubMed Web of Science ®Google Scholar
• Boland MV, Chang DS, Frazier T, Plyler R, Jefferys JL, Friedman DS. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study. JAMA Ophthalmol. 2014;132(7):845–850. doi:https://doi.org/10.1001/jamaophthalmol.2014.857.
   PubMed Web of Science ®Google Scholar
• Saeedi OJ, Luzuriaga C, Ellish N, Robin A. Potential limitations of e-mail and text messaging in improving adherence in glaucoma and ocular hypertension. J Glaucoma. 2015;24(5):e95–e102. doi:https://doi.org/10.1097/IJG.0000000000000150.
   PubMed Web of Science ®Google Scholar